Literature DB >> 11653041

Exploitation in the use of human subjects for medical experimentation: a re-examination of basic issues.

Leonardo D De Castro.   

Abstract

Relatively subtle forms of exploitation of human subjects may arise from the inefficiency or incompetence of a researcher, from the existence of a power imbalance between principal and subject, or from the uneven distribution of research risks among various segments of the population. A powerful and knowledgeable person (or institution) may perpetrate the exploitation of an unempowered and ignorant individual even without intending to. There is an ethical burden on the former to protect the interests of the vulnerable. Excessive or insufficient compensation may be exploitative. However, genuine economic imperatives motivating needy volunteers have to be considered. These forms of exploitation should be appreciated in the context of social and cultural factors suggesting that the relationship between researcher and subject cannot properly be appraised as a contractual undertaking. While compliance with pertinent codes and regulations minimises the exploitative potential, they cannot be enforced in a way that does not recognize a society's peculiar characteristics. The experience with some Filipino cultural traits illustrates this point.

Entities:  

Keywords:  Biomedical and Behavioral Research

Mesh:

Year:  1995        PMID: 11653041     DOI: 10.1111/j.1467-8519.1995.tb00360.x

Source DB:  PubMed          Journal:  Bioethics        ISSN: 0269-9702            Impact factor:   1.898


  3 in total

1.  Paying research subjects: participants' perspectives.

Authors:  M L Russell; D G Moralejo; E D Burgess
Journal:  J Med Ethics       Date:  2000-04       Impact factor: 2.903

2.  Payments to normal healthy volunteers in phase 1 trials: avoiding undue influence while distributing fairly the burdens of research participation.

Authors:  Ana S Iltis
Journal:  J Med Philos       Date:  2009-02-03

3.  A Participant-Centered Approach to Understanding Risks and Benefits of Participation in Research Informed by the Kidney Precision Medicine Project.

Authors:  Catherine R Butler; Paul S Appelbaum; Heather Ascani; Mark Aulisio; Catherine E Campbell; Ian H de Boer; Ashveena L Dighe; Daniel E Hall; Jonathan Himmelfarb; Richard Knight; Karla Mehl; Raghavan Murugan; Sylvia E Rosas; John R Sedor; John F O'Toole; Katherine R Tuttle; Sushrut S Waikar; Michael Freeman
Journal:  Am J Kidney Dis       Date:  2021-12-04       Impact factor: 11.072

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.